Evidence map›Paper›PMID 41590120›Full record

ArticleGels (Basel, Switzerland)2026

Effect of Driving Pressure Modes on Microjet Dispersion Characteristics in Tissue-Mimicking Gels for Large-Volume Needle-Free Injection.

Dongping Zeng, Longsheng Luo, Linxing Luo, Wei Wang, Jiamin Li

Abstract read
In one paragraph

Article in Gels (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dongping ZengSchool of Energy and Power Engineering, Changsha University of Science and Technology, Changsha 410114, China.ORCID 0000-0003-0157-317X
Longsheng LuoSchool of Energy and Power Engineering, Changsha University of Science and Technology, Changsha 410114, China.
Linxing LuoSchool of Energy and Power Engineering, Changsha University of Science and Technology, Changsha 410114, China.
Wei WangSchool of Energy and Power Engineering, Changsha University of Science and Technology, Changsha 410114, China.
Jiamin LiHubei Key Laboratory of Waterjet Theory and New Technology, Wuhan University, Wuhan 430072, China.

Funding

National Natural Science Foundation of China 52506041
6 · The paper itself

Abstract

Needle-free injection (NFI) technology is a promising alternative to conventional syringe injection, as it mitigates needle-related complications and enhances patient compliance. However, achieving the controlled and efficient dispersion of larger-volume formulations (>1 mL) within tissues remains a significant challenge. This study presents a novel pneumatic NFI system that uses a two-phase driving mode to regulate driving pressure and duration with an ejection volume of 1.0-2.0 mL. The integrated pressure stabilization unit significantly reduces pressure fluctuations during the initial injection phase, generating a more stable and uniform spray distribution. It is designed to produce an ideal elliptical dispersion effect while eliminating splatter, enabling controlled large-volume delivery. Jet impact experiments were conducted to investigate the dynamic characteristics of microjets generated by conventional single-phase and novel two-phase driving modes. Furthermore, the influence of the driving mode on the dispersion behaviors of microjets in agarose gels was explored through high-speed imaging of gel injections. The results demonstrate that the two-phase driving mode produces a distinct two-phase jet pressure profile. Compared to the single-phase mode, the two-phase mode produced a significantly larger dispersion width at equivalent initial driving pressures. This promotes more uniform lateral drug distribution and achieves a higher percentage of liquid drug delivery in gels. Furthermore, favorable driving pressure combinations were identified for different volumes: (1.25-0.25) MPa for 1.0 mL, (1.25-0.50) MPa for 1.5 mL, and (1.50-0.50) MPa for 2.0 mL. This provides a practical basis for optimizing clinical parameters and advancing the development of controllable NFI systems.

Indexed as

agarose geldispersion characteristicdriving modegel injectionneedle-free injection

Identifiers

PMID41590120
PMCPMC12840699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.